Colitis in transgenic and knockout animals as models of human inflammatory bowel disease

Immunological Reviews

Volumn 169, Issue , 1999, Pages 195-207

  Bhan, Atul K ^a   Mizoguchi, Emiko ^a   Smith, R Neal ^a   Mizoguchi, Atsushi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EXPERIMENTAL MODEL; HELPER CELL; HEREDITY; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KNOCKOUT GENE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC ANIMAL; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, BACTERIAL; AUTOANTIBODIES; B-LYMPHOCYTES; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE; HELICOBACTER; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0032805892     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01316.x     Document Type: Review

References (135)

1. 1. Bhan AK, Mizoguchi E, Mizoguchi A. New models of chronic intestinal inflammation. Curr Opin Gastroenterol 1994;10:633-638.
2. 2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928-937.
3. 3. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-1112.
4. 4. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274-282.
5. 5. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261.
6. 6. Kuhn R, Lohler J, Rennnick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
7. 7. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995;3:521-530.
8. 8. Mizoguchi A, Mizoguchi E, Bhan AK. The critical role of interleukin-4 but not interferon-γ in the pathogenesis of colitis in T cell receptor α mutant mice. Gastroenterology 1999;116:320-326.
9. 9. Rath HC, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest 1996;98:945-953.
10. high T cells to SCID recipients. J Immunol 1997;158:3464-3473.
11. 11. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptor-α β-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997;150:91-97.
12. 12. Sellon RK, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-5231.
13. 13. Mizoguchi E, Mizoguchi A, Bhan AK. Role of cytokines in the early stages of chronic colitis in TCRα-mutant mice. Lab Invest 1997;76:385-397.
14. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618-2625.
15. 15. Simpson SJ, et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J Exp Med 1998;187:1225-1234.
16. 16. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995;3:171-174.
17. 17. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med 1997;186:1749-1756.
18. 18. Kroemer G, Martinez C. Mechanisms of self tolerance. Immunol Today 1992;13:401-404.
19. 19. Lehmann PV, Targoni OS, Forsthuber TG. Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol Rev 1998;164:53-61.
20. 20. Levelt CN, Mizoguchi E, Huang X, Zacks R, Bhan AK, Tonegawa S. Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide. Proc Natl Acad Sci USA 1998;95:14349-14354.
21. 21. Von Boehmer H, et al. Crucial function of the pre-T-cell receptor (TCR) in TCRβ selection, TCRβ allelic exclusion and α β versus γ-δ lineage commitment. Immunol Rev 1998;165:111-119.
22. 22. Bruno L, Rocha B, Rolink A, von Boehmer H, Rodewald HR. Intra-and extra-thymic expression of the pre-T cell receptor α gene. Eur J Immunol 1995;25:1877-1882.
23. 23. Saint-Ruf C, Lechner O, Feinberg J, von Boehmer H. Genomic structure of the human pre-T cell receptor α chain and expression of two mRNA isoforms. Immunol Today 1998;14:131-136.
24. 24. Mombaerts P, et al. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 1992;360:225-231.
25. 25. Mombaerts P, et al. Peripheral lymphoid development and function in TCR mutant mice. Int Immunol 1994;6:1061-1070.
26. 26. Mizoguchi A, et al. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996;183:847-856.
27. 27. Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK. Role of appendix in the development of inflammatory bowel disease in TCR-α mutant mice. J Exp Med 1996;184:707-715.
28. 28. Hollander GA, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995;3:27-38.
29. 29. Ludviksson BR, Gray B, Strober W, Ehrhardt RO. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J Immunol 1997;158:104-111.
30. 30. Clegg CH, et al. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int Immunol 1997;9:1111-1122.
31. 31. Janeway CA Jr. A tale of two T cells. Immunity 1998;8:391-394.
32. + lymphocytes in chronic inflammatory bowel disease. J Immunol 1996;157:3183-3191.
33. -/- mice. J Immunol 1995;154:1569-1576.
34. 34. Wen L, et al. Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non α/β" T cells. J Exp Med 1996;183:2271-2282.
35. 35. Mombaerts P, Terhorst C, Jacks T, Tonegawa S, Sancho J. Characterization of immature thymocyte lines derived from T-cell receptor or recombination activating gene 1 and p53 double mutant mice. Proc Natl Acad Sci USA 1995;92:7420-7424.
36. 36. Barber DF, Passoni L, Wen L, Geng L, Hayday AC. The expression in vivo of a second isoform of pTα: implications for the mechanism of pTα action. J Immunol 1998;161:11-16.
37. 37. Mizoguchi A, Mizoguchi E, Bhan AK. The appendix is a priming site for the development of chronic colitis in TCRα-mutant mice. Gastroenterology 1997;112:A1043.
38. + T cells in TCRα-chain deficient mice by gut-derived antigens. J Immunol 1999;162:1843-1850.
39. 39. Targan SR. The search for pathogenic antigens in ulcerative colitis. Gastroenterology 1998;114:1099-1100.
40. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998;187:855-864.
41. 41. Mizoguchi A, Mizoguchi E, Tonegawa S, Bhan AK. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCRα mutant mice with inflammatory bowel disease. Int Immunol 1996;8:1387-1394.
42. 42. Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-116.
43. 43. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997;156:145-166.
44. 44. Gaskins HR, Vondrak-Juergens GL, McCracken BA, Woolsey JH. Specific-pathogen-free conditions enhance inflammatory bowel disease in T-cell receptor knockout, but not C3H/HeJBir mice. Lab Anim Sci 1997;47:650-655.
45. 45. Foltz CJ, et al. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 1998;3:69-78.
46. 46. Kullberg MC, et al. Helicobacter hepaticus triggers colitis in specific pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12 and γ interferon-dependent mechanism. Infect Immun 1998;66:5157-5166.
47. 47. Owen RL. M cells - entryways of opportunity for enteropathogens. J Exp Med 1994;180:7-9.
48. 48. Bhalla DK, Owen RL. Cell renewal and migration in lymphoid follicles of Peyer's patches and cecum - an autoradiographic study in mice. Gastroenterology 1982;82:232-242.
49. 49. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-767.
50. 50. Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994;106:1251-1253.
51. 51. O'Gorman P, et al. MALTectomy (appendectomy/tonsillectomy) does not influence the occurrence or mode of presentation of adult celiac disease. Am J Gastroenterol 1996;91:723-725.
52. 52. Russel MG, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997;113:377-382.
53. 53. Duggan AE, Usmani I, Neal KR, Logan RFA. Appendectomy, childhood hygeine, Helicobacter pylori, and risk of inflammatory bowel disease: a case control study. Gut 1998;43:494-498.
54. 54. Rath HC, Ikeda JS, Linde HJ, Scholmerich J, Wilson KH, Sartor RB. Varying cecal bacterial loads influence colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1999;116:310-319.
55. 55. Hanninen A, Jaakkola I, Jalkanen S. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol 1998;160:6018-6025.
56. + αβ T cells in lpr mice: the appendix in normal mice. J Immunol 1998;160:2665-2674.
57. 57. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
58. 58. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275-283.
59. 59. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
60. 60. Lafaille JJ, et al. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 1997;186:307-312.
61. 61. Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 1997;186:299-306.
62. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-1270.
63. 63. Parronchi P, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-832.
64. 64. Strober W, Fuss IJ, Ehrhardt RO, Neurath M, Boirivant M, Ludviksson BR. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol 1998;48:453-458.
65. 65. Neurath MF, Fuss I, Schurmann G. Upregulation of the IL-12/STAT-4 signaling pathway distinguishes Crohn's disease from ulcerative colitis. Gastroenterology 1998;114:G4299.
66. 66. Mackay F, et al. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 1998;115:1464-1475.
67. 67. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-1290.
68. + T cells and proinflammatory Th1-type cytokines. J Immunol 1997;158:1068-1077.
69. 69. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 1998;161:3143-3149.
70. 70. Ehrhardt RO, Ludviksson BR, Gray B, Neurath M, Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997;158:566-573.
71. 71. Takeda K, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
72. 72. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J Exp Med 1996;183:2605-2616.
73. + T cells. Am J Pathol 1996;148:1503-1515.
74. 74. Bertrand V, et al. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human β 2-microglobulin. Eur Cytokine Netw 1998;9:161-170.
75. 75. Mizoguchi E, Mizoguchi A, Chiba C, Niles JL, Bhan AK. Antineutrophil cytoplasmic antibodies in T-cell receptor α deficient mice with chronic colitis. Gastroenterology 1997;113:1828-1835.
76. + T-cell population mediates development of inflammatory bowel disease in T-cell receptor a chain-deficient mice. Gastroenterology 1997;112:1876-1886.
77. 77. Teague TK, Marrack P, Kappler JW, Vella AT. IL-6 rescues resting mouse T cells from apoptosis. J Immunol 1997;158:5791-5796.
78. + T cells. J Exp Med 1997;185:461-469.
79. 79. Samoilova EB, Horton JL, Hilliard B, Lin TST, Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: role of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 1998;161:6480-6486.
80. 80. Drakesmith H. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen. Proc Natl Acad Sci USA 1998;95:14903-14908.
81. 81. Targan SR, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-1035.
82. + T cells by antigenic peptides altered for TCR binding. J Immunol 1997;158:4237-4244.
83. 83. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N. Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 1995;181:41-53.
84. 84. Marrack P, et al. T-cell survival. Immunol Rev 1998;165:279-285.
85. 85. Watanabe M, et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 1998;187:389-402.
86. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
87. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
88. 88. Hagenbaugh A, et al. Altered immune responses in interleukin 10 transgenic mice. J Exp Med 1997;185:2101-2110.
89. 89. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
90. 90. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998;188:1929-1939.
91. 91. Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 1998;28:2780-2790.
92. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 1998;188:1883-1894.
93. + T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J Exp Med 1998;188:1875-1882.
94. 94. Lehuen A, et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998;188:1831-1839.
95. 95. Taniguchi M, et al. Essential requirement of an invariant V α 14 T cell antigen receptor expression in the development of natural killer T cells. Proc Natl Acad Sci USA 1996;93:11015-11018.
96. 96. Seibold F, Brandwein S, Simpson S, Terhorst C, Elson CO. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol 1998;18:153-160.
97. + T cells from scid mice with inflammatory bowel disease. Eur J Immunol 1998;28:3655-3663.
98. 98. Ma A, Datta M, Margosian E, Chen J, Horak I. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 1995;182:1567-1572.
99. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996;184:241-251.
100. 100. Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A. Perinuclear antineutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 1995;155:3262-3267.
101. 101. Geng X, et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology 1998;114:912-922.
102. + T cells. Nature 1994;369:654-658.
103. 103. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996;184:2271-2278.
104. 104. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-136.
105. 105. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-392.
106. 106. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-351.
107. 107. Mayer L, Shlien R. Evidence for function of 1a molecules on gut epithelial cells in man. J Exp Med 1987;166:1471-1483.
108. 108. Panja A, Barone A, Mayer L. Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements. J Exp Med 1994;179:943-950.
109. 109. Toy LS, Yio XY, Lin A, Honig S, Mayer L. Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest 1997;100:2062-2071.
110. 110. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-1207.
111. 111. Baribault H, Penner J, Jozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994;8:2964-2973.
112. 112. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance, mdr1a, spontaneously develop colitis. J Immunol 1998;161:5733-5744.
113. 113. Dignass AU, Tsunekawa S, Podolsky DK. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 1994;106:1254-1262.
114. 114. Koh TJ, et al. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997;113:1015-1025.
115. 115. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-265.
116. 116. Boismenu R, Havran WL. γδ T cells in host defense and epithelial cell biology. Clin Immunol Immunopathol 1998;86:121-133.
117. 117. Egger B, et al. Mice lacking transforming growth factor α have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 1997;113:825-832.
118. 118. Yamamoto M, Fujihashi K, Kawabata K, McGhee JR, Kiyono H. A mucosal intranet: intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes. J Immunol 1998;160:2188-2196.
119. 119. Komano H, et al. Homeostatic regulation of intestinal epithelia by intraepithelial γδ T cells. Proc Natl Acad Sci USA 1995;92:6147-6151.
120. 120. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science 1994;266:1253-1255.
121. 121. Boismenu R, Feng L, Xia YY, Chang JC, Havran WL. Chemokine expression by intraepithelial γδ T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol 1996;157:985-992.
122. 122. Hayday A, Geng L. γδ cells regulate autoimmunity. Curr Opin Immunol 1997;9:884-889.
123. + TH1-like responses. J Clin Invest 1996;98:1010-1020.
124. 124. Meijssen MA, Brandwein SL, Reinecker HC, Bhan AK, Podolsky DK. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am J Physiol 1998;274: G472-G479.
125. 125. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor β. Gastroenterology 1993;105:1323-1332.
126. 126. Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expressions of interleukin-8. Gastroenterology 1993;105:1689-1697.
127. 127. Reinecker HC, Podolsky DK. Human intestinal epithelial cells express functional cytokine receptors sharing the common γc chain of interleukin 2 receptor. Proc Natl Acad Sci USA 1995;92:8353-8357.
128. 128. Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996;111:1706-1713.
129. 129. Shirato K, LeDuy L, Yuan SY, Jothy S. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch 1990;58:303-308.
130. 130. Keates S, Keates AC, Mizoguchi E, Bhan AK, Kelly CP. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. Am J Physiol 1997;273:G75-G82.
131. 131. Hogaboam CM, et al. Therapeutic effects of interleukin 4 gene transfer in experimental inflammatory bowel disease. J Clin Invest 1997;100:2766-2776.
132. 132. Shull MM, et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammation. Nature 1992;359:693-699.
133. 133. Rudolph U, et al. Ulcerative colitis and adenocarcinoma of the colon in Gα12-deficient mice. Nat Genet 1995;10:143-150.
134. 134. Snapper SB, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998;9:81-91.
135. 135. Bush TG, et al. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998;93:189-201.